144 related articles for article (PubMed ID: 8236510)
1. A calcitonin-producing neuroendocrine tumor of the larynx: a case report.
Insabato L; De Rosa G; Terracciano LM; Lupoli G; Montedoro D; Ravetto C
Tumori; 1993 Jun; 79(3):227-30. PubMed ID: 8236510
[TBL] [Abstract][Full Text] [Related]
2. Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature.
Feola T; Puliani G; Sesti F; Modica R; Biffoni M; Di Gioia C; Carletti R; Anastasi E; Di Vito V; Centello R; Lenzi A; Isidori AM; Faggiano A; Giannetta E
Front Endocrinol (Lausanne); 2020; 11():397. PubMed ID: 32765421
[No Abstract] [Full Text] [Related]
3. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
Hirsch MS; Faquin WC; Krane JF
Mod Pathol; 2004 Jun; 17(6):631-6. PubMed ID: 15098009
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive surgery for recurrent neuroendocrine carcinoma of the supraglottic larynx.
Machens A; Holzhausen HJ; Dralle H
Eur Arch Otorhinolaryngol; 1999; 256(5):242-6. PubMed ID: 10392299
[TBL] [Abstract][Full Text] [Related]
5. [Laryngeal neuroendocrine carcinoma. Report of a clinical case].
Balderrama Caballero DH; Dreier Spickernagel AL; Guerrero Alonso CJ; Relea Calatayud MF; Campos de Orellana Gómez AM
Acta Otorrinolaringol Esp; 1995; 46(2):149-51. PubMed ID: 7598968
[TBL] [Abstract][Full Text] [Related]
6. Metastasizing neuroendocrine carcinoma of the larynx with calcitonin and somatostatin secretion and CEA production, resembling medullary thyroid carcinoma.
Smets G; Warson F; Dehou MF; Storme G; Sacré R; Van Belle S; Somers G; Gepts W; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1990; 416(6):539-43. PubMed ID: 1970917
[TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrine carcinoma of the larynx with secretion of calcitonin: primary tumor or metastasis of the medullary thyroid carcinoma?].
Vildé F; Arkwright S; Paoli C; Périchon I; Le Charpentier Y; Le Bodic MF
Ann Pathol; 1996; 16(2):104-7. PubMed ID: 8767676
[TBL] [Abstract][Full Text] [Related]
8. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells.
Chung JH; Lee SS; Shim YS; Kim SY; Nam SY; Kim DH; Cho KJ
Laryngoscope; 2004 Jul; 114(7):1264-70. PubMed ID: 15235358
[TBL] [Abstract][Full Text] [Related]
9. Primary calcitonin-secreting neuroendocrine carcinoma of the supraglottic larynx.
Hakeem AH; Pradhan S; Bhele S; Tubachi J
Ear Nose Throat J; 2015 Jan; 94(1):E34-5. PubMed ID: 25606844
[No Abstract] [Full Text] [Related]
10. Neuroendocrine neoplasms of the larynx.
Overholt SM; Donovan DT; Schwartz MR; Laucirica R; Green LK; Alford BR
Laryngoscope; 1995 Aug; 105(8 Pt 1):789-94. PubMed ID: 7630288
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma of the larynx with mucosubstance production and neuroendocrine differentiation: an ultrastructural and immunohistochemical study.
Paladugu RR; Nathwani BN; Goodstein J; Dardi LE; Memoli VE; Gould VE
Cancer; 1982 Jan; 49(2):343-9. PubMed ID: 6119151
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
13. Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.
Hunt JL; Barnes L; Triantafyllou A; Gnepp DR; Devaney KO; Stenman G; Halmos GB; Bishop JA; Skálová A; Willems SM; Hellquist H; Rinaldo A; Ferlito A
Adv Anat Pathol; 2019 Jul; 26(4):246-250. PubMed ID: 31033507
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid on 68Ga DOTANOC PET-CT.
Tripathy S; Aggrawal S; Subudhi K; Kumar R; Narwal A
Clin Nucl Med; 2019 Sep; 44(9):e546-e547. PubMed ID: 31283604
[TBL] [Abstract][Full Text] [Related]
15. [Neuroendocrine tumor of the larynx. Report of a case].
Guerzider P; Fiche M; Beauvillain C; Le Bodic MF
Ann Pathol; 1991; 11(4):253-6. PubMed ID: 1659825
[TBL] [Abstract][Full Text] [Related]
16. Infiltrating, moderately differentiated neuroendocrine tumor of the larynx: a brief report.
Shemen L; Petratos P; Patel S; Horowitz L
Ear Nose Throat J; 2003 Mar; 82(3):205-7. PubMed ID: 12696242
[TBL] [Abstract][Full Text] [Related]
17. [Calcitonin-producing neuroendocrine carcinoma of the larynx: atypical carcinoid tumor].
Morales C; Tomás Bezos J; Alvarez-Quiñones Sanz M; García Mantilla J; Carrera F
Acta Otorrinolaringol Esp; 1996; 47(4):333-5. PubMed ID: 8962741
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin-Secreting Neuroendocrine Carcinoma of Larynx with Metastasis to Thyroid.
LaBryer L; Sawh R; McLaurin C; Scofield RH
Case Rep Endocrinol; 2015; 2015():606389. PubMed ID: 26491576
[TBL] [Abstract][Full Text] [Related]
19. Pathologic quiz case 2. Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) of the larynx.
Steinberg DM; Kashima HK
Arch Otolaryngol Head Neck Surg; 1998 Feb; 124(2):219, 221-2. PubMed ID: 9485118
[No Abstract] [Full Text] [Related]
20. Hypercalcitoninemia in a sporadic asymptomatic neuroendocrine tumor of the pancreatic tail.
Machens A; Haedecke J; Hinze R; Thomusch O; Schneyer U; Dralle H
Dig Surg; 2000; 17(5):522-4. PubMed ID: 11124561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]